Log In
Print this Print this

Zembrace SymTouch, sumatriptan succinate

  Manage Alerts
Collapse Summary General Information
Company Dr. Reddy's Laboratories Ltd.
DescriptionSumatriptan, a selective serotonin (5-HT1B) and 5-HT1D receptor agonist, delivered using a prefilled, ready-to-use, single-dose disposable autoinjector
Molecular Target Serotonin (5-HT1B) receptor ; Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat acute migraine, with or without aura, in adults who are inadequately managed with existing treatment regimens
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today